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Kinetics of the incorporation of dietary fatty acids 
into serum cholesteryl esters, erythrocyte 
membranes, and adipose tissue: an 18-month 
controlled study 
Martijn B. Katan,’.’Jean Paul De~lypere,’.~ Angelique P. J. M. van Birgelen, 
Margriet Penders: and Marianne Zegwaard 
Department of Human Nutrition, Wageningen Agricultural University, Bomenweg 2 ,  6703 I - I D  
Wagen ingen , The Net herlands 
Abstract. Tissue levels of 11-3 Fatty acids reflect dietar) in- 
take, but quantitative data ahout rate of incorporation and 
levels as a function of intake are scarce. We fed 58 men 0, 3, 
6, or 9 g / d  of fish oil for 12 months arid monitored fatty acids 
i l l  serum cholesteryl esters, erythrocytes, and siibciitaneoiis Fat 
during and after supplementation. Eicosapentaenoic acid 
(EPA) in cholesteryl esters plateaued after 4-8 weeks; the in- 
corporation half-life was 4.8 days. Steady-state levels increased 
by 3.9 i 0.3 mass % points (i SE) for each extra gram of 
EPA eaten per day. Incorporation of docosahexaenoic acid 
(DHA) was erratic; plateau valiies were 1.1 i 0.1 mass ‘ib 
higher for evety g /d  ingested. Incorporation of EPA into 
erythrocyte membranes showed a half-life of28 days; a steady 
state was reached after 180 days. Each g/d increased levels by 
2.1 i 0.1 inass %. C22:5n-3 levels increased niarkedly. 
(:hanges in DHA were erratic and smaller. EPA levels in adi- 
pose tissue rose also; the change after 6 months was 67% of 
that after 12 months in gluteal and 75% in abdominal Lit. 
After 12 months each grarn per day caused an 0.11 +- 0.01 
mass % rise in gluteal fat for EPA, 0.53 2 0.07 for C22:5n- 
3, and 0.14 2 0.03 for DH.4.u Thus, different (11-3) fatty 
acids were incorporated with different efficiencies, possihly 
because of interconversions or different affinities of the eniy- 
matic pathways involved. EPA levels in cholesteryl esters re- 
flect intake over the past week or two, erythrocytes over the 
past month or two, and adipose tissue over ;I period of years. 
These findings may help in assessing the intake of (n-3) fatty 
acids in epidemiological studies.-Katan, M. B., J. P. Deslyp- 
ere, A. P. J. M. van Birgelen, M. Penders, and M. Z e p w d .  
Kinetics of the incorporation of dietar?, 11-3 fatty acids into 
serum cholesteryl esters, erythrocyte menibranes, and adipose 
tissue: an 18-month controlled study. ,/. l i p i d  fh. 1997. 38: 
‘Lo1 2-2022. 
Supplementary key words n-3 polyunsatiirated fatty acids diet 
fish oil rholestcryl esters erythrocytes adipose tissue, hiomarkrrs 
of intake 
The human body has an absolute requirement for 
polyunsaturated fatty acids of both the n-6 (omega 6) 
and the n-3 series. These essential fatty acids occur in  
the body in a variety of forms, which include phospho- 
lipids in membranes, fatty acid esters of cholesterol and 
other lipids circulating in the blood or stored i n  cells, 
and triglycerides stored in adipose tissue. Although the 
fatty acid composition of membrane phospholipids and 
cholesteryl esters is under homeostatic control i t  also 
reflects dietary intake (1-12). This is even more so f b r  
storage of triglycerides (13). The proportion of linoleic 
acid, and increasingly also that of eicosapentaenoic acid 
(C20:5n-3, EPA) in plasma or adipose tissue are thet-e- 
fore used as a marker of intake (IO, 14). A number of 
studies have indeed shown significant correlations bc- 
tween intake and plasma o r  adipose tissue levels of eico- 
sapentaenoic and/or docosahexaenoic acid ( ( 2 2 :  (in- 
3, DHA) (15-21). It is also clear that different plasma 
lipid classes reflect changes in intake at different rates, 
and that adipose tissue is slowest of all i n  reaching a 
new steady state. However, rational use of tissue o r  
plasma fatty acids as indicators of intake requires two 
types of quantitative data: the time frame of intake 
which a specific marker represents, and the quantitativr 
change in the tissue or plasma fatty acid per g of  fatty 
acid consumed. Little such information is presently 
;wailable. 
The present study aimed to provide such data. We 
report herein the rate and extent to which EPA, docosa- 
Abhrc\iatioiis: I.(A’l., Iecithit~:rtiolesterol a( 
hutylatetl hydroxytoluene (:!,ti-di-tert-hutyl-p-c 
pentaenoic acid; DHA, docosahexaenoic acid; 
; i i i i i r i r  tetraacetate; LDL, low density lipoprotein. 
\Joint lirst authors. 
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ITniversity of North (Lirolina, (;Ilapcl Hill, N(;. 
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pentaenoic acid (C22 : 5n-3), and DHA were incorpo- 
rated into cholesteryl esters, erythrocyte membranes, 
and adipose tissue in volunteers as a function of dosage 
and duration in an 18-month controlled trial. 
SUBJECTS, MATERIALS AND METHODS 
Subjects 
Fifty-eight monks from one Trappist and three Bene- 
dictine monasteries participated in the study. Their 
mean age (kSD) was 56.2 t 16.5 years. We excluded 
subjects who used drugs that influence lipid metabolism 
or the cyclo-oxygenase enzyme (Le., non-steroidal anti- 
inflammatory drugs), and subjects with serious illnesses 
(diabetes, cancer, or coronary heart disease), a body 
mass index greater than 30 kg/m', a systolic blood pres- 
sure above 160 mmHg or a diastolic blood pressure 
above 95 mmHg, total cholesterol > 7 mmol/l or tri- 
glycerides > 3 mmol/l, and age younger than 21 or 
older than 90 years. Ten participants ate lacto-ovovege- 
tarian diets exclusively. 
The protocol of the study was approved by the Hu- 
man Ethics Committee of the Department of Human 
Nutrition, and all volunteers gave their written consent 
after having been thoroughly informed about the na- 
ture of the study. 
Design and supplements 
The study consisted of a 2-week base-line period, fol- 
lowed by a l-year treatment with fish oil and a 6-month 
wash-out period. Within each monastery subjecb were 
randomly divided into four groups, which received each 
day during the 12-month treatment period either 0 (n 
= 14), 3 (n = 15), 6 (n = 15), or 9 (n = 14) capsules, 
each containing I gram of fish oil. The oil consisted 
of triglycerides, not synthetic esters. In each group the 
number of capsules was made up to 9 by adding 9, 6, 
3, or 0 placebo capsules, respectively. Thus every subject 
received 9 g of oil per day on top of his normal intake. 
Three capsules were taken at each meal. We performed 
a capsule count and delivered new capsules every 2 
months. 
A11 capsules were provided by S.A. Sanofi Labaz Inc. 
(Brussels, Belgium). The placebo capsules contained ol- 
ive oil (Puget, Marseille, France) plus palm oil (Loders 
Croklaan, Wormerveer, The Netherlands) to which 
cholesterol (Merck, Darmstadt, Germany) and vitamin 
E (Organon, Oss, The Netherlands) were added. The 
placebo oil was composed in such a way that the content 
of saturated fatty acids, vitamin E, and cholesterol was 
equal and that of linoleic acid nearly equal to that in 
TABLE 1 .  Composition of the fish oil and placebo capsules 
_ _ ~  ~ 
FdKy Acid Placebo Oil Fish Oil 
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20 : 511-3 
22: 1 n-9 
Y2: 611 -3 
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Each volunteer took 9 gram per day of fish oil, placebo oil, or n 
"Other peaks were either less than 0.5% or not identifiable. 
mixture of the two. 
the fish oil (Table 1). The study thus comprised a com- 
parison of monounsaturated fatty acids, which can be 
made in the body, with essential n-3 polyunsaturates, 
at a constant total intake of fat. The low fish oil group 
received 0.81 g EPA, 0.16 g DHA, and 0.09 g C 22:5n- 
3/d, the middle group 1.62, 0.33, and 0.18 g/d, and 
the high fish oil group 2.43,0.49, and 0.27 g/d,  respec- 
tively. 
Blood sampling and a clinical examination were done 
12 times during the trial, on days - 14,O (start of supple- 
mentation), 3, 7, 14, 28, 56, 182, 363 (end of supple- 
mentation), 396,424, and 536 (end of washout period). 
Subjects kept records of everything they ate and drank 
for 3 days on days - 3  to -1, 179 to 181, and 360 to 
362. These records were each time supplemented by a 
dietary history interview of every subject by a trained 
dietician who weighed portion sizes and foods. Nutrient 
intakes were calculated using the Netherlands Nutrient 
Data Bank supplemented with figures for EPA and DHA 
contents of foods. 
All subjece recorded any illnesses, use of drugs, alco- 
hol intake, omission of capsule intake, and other rele- 
vant facts in a diary. 
Sampling and storage 
Venous blood was drawn after an overnight fast into 
one 10-ml Vacutainer tube containing EDTA and an- 
other one without anticoagulant. Serum was stored at 
-70°C and used for the analysis of cholesteryl esters. 
The EDTA tubes were centrifuged on the spot at low 
speed and 4°C to isolate red blood cells. The cells were 
washed twice with ice-cold isotonic saline, transferred 















into stoppered plastic tubes, and hemolyzed by freezing 
at -80°C for at least 2 h. The hemolysates were stored 
at -20°C for a maximum of 7 days before further pro- 
cessing. 
Both gluteal (buttock) and abdominal subcutaneous 
fat aspirates were taken at days 0, 182, and 363 by the 
method of Beynen and Katan (22) using evacuated 10- 
ml tubes instead of a syringe. Abdominal subcutaneous 
fat microbiopsies were taken 2-3 cni to the left of the 
umbilicus. A final gluteal sample was taken at day 536; 
the abdominal sampling was omitted because of possi- 
ble discomfort to subjects. The amount of fat obtained 
was 20 to 100 mg. Samples were stored at -XO"(;. 
Chemical analyses 
Serum cholesteryl ester fatty acids were analyzed 
largely as previously described ( 11). All glassware was 
washed twice with distilled water and once with hexane. 
Antioxidant BHT (2,6-di-tert-butyl-pcresol, BDH Bio- 
chemicals, Poole, UK) was added to the isopropanol 
and n-octane to a final concentration of 0.005%. The 
fatty acids were analyzed with a gas chromatograph 
(Packard 438 AS United Technologies, Delft, The Neth- 
erlands), using a 50-m fused silica column (inside diarn- 
eter 0.25 mm) coated with 0.2 pm CP Si1 88 (Chrom- 
pack, Middelburg, The Netherlands). The injection 
volume was 1 pl and the split ratio was 30: 1. Nitrogen 
was used as carrier gas at a flow of 20 ml/min and a 
pressure of 120 kPa. The oven temperature was pro- 
grammed to rise after 3 niin of steady state from 160°C 
to 215°C at a rate of 3"C/min during the first 2 min 
followed by a rate of 15"C/min, and then kept constant 
at 215°C. The temperature of the injector was 225°C 
and that of the hydrogen flame ionization detector was 
250°C. Peak areas were measured with an electronic 
integrator (SP 4100, Spectra Physics, Santa Clara, CA). 
Fatty acids were identified by comparison with known 
standards (Chrompack, Middelburg, the Netherlands) . 
The sum of all peak areas of the fatty acids identified 
was taken as 100%. A quality control serum pool was 
analyzed in duplicate in each run. Over a 4-month pe- 
riod the combined within and between run coeffi- 
cient of variation was 4-12% for EPA and 3-8% for 
DHA. 
For analysis of erythrocyte fatty acids, 0.5 g of hemoly- 
sate was mixed with 4.5 mL isopropanol, 6 mL, hexane 
containing 50 mg of BHT per L was added, the tubes 
were shaken for 45 min, and the clear supernatant was 
poured off and centrifuged for 5 min at 1200 g a t  4°C. 
Four mL of the upper layer was dried down at 60°C 
under a stream of nitrogen and phospholipids were 
transmethylated by mixing with 4 mL of acid methanol 
(40 mL H,S04/L methanol) and incubating at 60°C 
for 18 h as previously described (11). The methyl esters 
werc extracted from the mixture with hexane and ana- 
lyzed by gas-liquid chromatography as described above,, 
except that the temperature program involved an initi;tl 
3 min at 145"C, an increase of 3"C:/min for 2 min, and 
a further increase of 25"C/min to a final temperatui.c~ 
o f  215°C:. Injector and detector temperatul-t.s ~ c r t '  
250°C. A quality control pool of fatty acids froin hrnio- 
lyzed erythrocytes was analyzed in duplicate i n  cach I - t in ;  
the combined within and between run coefficients 01' 
variation over a 4-month period was 6-12'ib f i r  EPA. 
6-896 for C22:.3n-3, and 3-5% fbr DHA. 
Analysis and quality control procedures for tat tissue 
aspirates have been previously described (23). 
Mathematical modeling and statistical analysis 
The proportion of EPA or DI-IA in cholesteryl esters 
or erythrocyte membranes as a function of time was 
modelled with the equation: 
C(t) = C(w) - [C:(m) - (;(())I e 
where C(t) is the proportion of the fatty acid of interest 
(mass% fatty acids) after t days of fish oil consumption, 
C(m)  is the final steady-state proportion, C(0) is the ini- 
tial proportion, and k is the rate constant. Essentially 
the Same equation was used by Dayton et al. (24) to 
model changes in adipose tissue linoleic acid in the Vet- 
erans Administration trial. Each subject's data were fit- 
ted to this equation using SAS procedure NLIN. This 
yielded estimates of the parameters C ( O ) ,  C(m) ,  and k 
which were then averaged per fatty acid per dosage 
group. The incorporation half-life t l  L' was then calcu- 
lated as t ,  L' = ln(2)/k. 
Statistical analysis was performed using t-tests or the 
two-tailed Wilcoxon rank sum test. Changes in fatty 
acids concentration were calculated as the value at a 
given point of time minus the baseline value, i.e., the 
mean of the values at day - 14 and day 0. We calculated 
slopes and intercepts of the mean changes of 11-3 fatty 
acids levels per dosage group over 12 months as a func- 
tion of the amount of 11-3 fatty acids supplied per clay. 
For example, the relation between EPA in cholesteryl 
esters at 363 days and EPA supplied was calculated using 
the model AY(g/lOO g) = a + b X X (g/d) + error, 
where AY is the mean change in cholesteryl ester EPA 
between baseline and day 363, and X is the aniount of 
extra EPA supplemented (0, 0.81, 1.62 or 2.43 g/d: cf 
Methods). 
RESULTS 
Compliance and food intake 
Throughout the study period the subjects showed an 
excellent compliance as judged from the capsule count 
and the regular visits to the monasteries. 















TABLE 2. Intake of vev-long-chain n-3 fatty acids of the volunteers at the start of the study 
and during supplementation 
Supplementation Group 
(means of t  = 6 and 12 months) 
Baseline 
( t  = 0) Zero I.0w Mid High 
n 57 14 15 15 14 
Fish oil (g/d) 0 0 3 6 9 
Placebo oil (g/d) 0 9 6 3 0 
DHA (g/d) 0.06 0.18 0.41 0.57 0.73 
EPA (g/d) 0.04 0.19 1.01 I .79 2.58 
C22:5n-3 (g/d) 0.00 0.00 0.09 0.17 0.26 
Intakes of EPA and DHA include those from foods as calculated from 3-day records. Figures for C22:5n- 
3 refer exclusively to intake from capsules, as no data for foods were available. 
Nutrient intake on the baseline diet was highly similar 
for the four dosage groups and it showed little change 
over the course of the trial. At weeks 6 and 12 com- 
bined, mean energy intake of the 58 men, including the 
contribution from oil supplements, was 9.7 MJ/d (2326 
kcal/d), with protein providing 12%, carbohydrates 
46%, alcohol 1%, total fat 41%, saturated fatty acids 
16%, monounsaturated fatty acids 14-15%, and linoleic 
acid 4-596; mean cholesterol intake was 373 mg/d. The 
intake of n-3 polyunsaturates from foods unfortunately 
showed some variation with time: EPA and DHA intakes 
from foods were 40 and 60 mg/d, respectively, at base- 
line, 368 and 352 mg/d at 6 months, and 112 and 117 
mg/d, respectively, at 12 months. The rise at 6 months 
was due to meat being replaced by fish during the pre- 
Christmas Advent period in the non-vegetarian Bene- 
dictine monasteries. The averages of intakes at 6 and 
12 months are shown in Table 2. The extra intake of 
n-3 fatty acids from foods was reflected in serum 
cholesteryl esters and erythrocytes. Brothers from abbey 
No 4, which reported the highest fish and n-3 fatty acid 
intake at 6 months (day 182), indeed showed the most 
marked elevation in erythrocyte and cholesteryl ester 
n-3 fatty acids at that time point. However, it occurred 
to about the same extent in the supplemented groups 
as in the concurrent placebo group, and as a result the 
effect was eliminated when all changes were calculated 
relative to changes in the placebo group. 
Cholesteryl esters 
The proportion of EPA in the cholesteryl esters was 
increased in all three fish oil groups at the first blood 
sampling, after 3 days of fish oil consumption (Fig. 1,  
top). The rise in EPA was compensated for largely by 
decreases in linoleic acid, with little change in arachi- 
donic acid (Table 3). Crude EPA levels were slightly ele- 
vated at 6 mo, reflecting the unscheduled intake of fish 
around this period (see above); thus levels in the con- 
trol group were 0.9 g/100 g at 0 and 12 mo, and 1.3 at 
6 mo. This effect disappeared when all changes were 
corrected for changes in the control group (Fig. 1, top). 
Using a first-order exponential model (see Methods) 
we calculated that half-maximal levels were reached 
after an average 4.8 days of supplementation (Table 4). 
The increase reached a plateau at 56 days (Fig. 1, top). 
After 1 year EPA concentrations in cholesteryl esters 
had changed by -5% in the placebo group, +367% in 










0 60 120 180 240 300 360 420 480 540 
Time (days) 
Fig. 1. Serum cholesteryl esters: changes in the levels of very-long- 
chain n-3 polyunsaturated fatty acids in volunteers supplemented for 
12 months with 0 g /d  (V, n = 14), 3 g/d (0, n = 15), 6 g/d (A,  
n = 15), or 9 g /d  (0, n = 14) of fish oil rich in EPA. Values represent 
changes from baseline corrected for changes in the placebo (0 g/d)  
group. Top: Eicosapentaenoic acid (EPA), C20: 5n-3. Bottom, docc- 
sahexaenoic acid (DHA), C22 :6n-3. Docnsapentaenoic acid (C22: 
5n-3) was not detectable. 















TABLE 3. Proportions of key essential fatty acids in cholesteryl esters and erythrocyte inenihr;riirs at the 
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20: 411-6 
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0.0 t- 0.4 0.9 t- 0.3 0.8 i 0.2 0.8 2 0.3 
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0.6 i O.? 0.5 i- 0.2  ,4.(i -c 0.fi 4.4 2 0.8 
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0.4 * I .6 9.0 -+ 1.4 
2.7 2 I . ( <  9.(i t 0.i 
0.8 2 0.2 2.8 t- 0.3 
2.5 2 0.3 . 'i9 i 0.3 
4.6 t- 0.6 4.(i t 0.5 
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1 1 . 0  t 1 . 1  
0.5 t 0 .3  
2.3 t- 0.2 
4.7 t- 0.h 
10.3 i 1.5 
12.2 t- 1.5 
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2 . 3  i 0 . 3  
4.4 t- 0.4 
X.7 i 1.2 
8.2 i 0.9 
4.3 2 0.0 
4.5 ? 0 . 5  
4.8 ? 0.5 
7.6 ? I .  I 
5.3 i 0.8 
5.11 i I.? 
5.0 i 0.4 
4.8 i 0.5 
TABLE 4. Kinetic paranieters <IC the incorpxtiori  of dietary very-long-chain n-J  fictty acids i n t o  pliisnia 
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" ( 2 2  :5n-3 was not detectable in cholestel?l esters. The time course of DHA i n  cnthroc!tcs could not hc 
'11 = 13 inste;d 01. 15 because data of one siil+xt could n o t  he fitted with thc motlt.1. 
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TABLE 5. Average change ( T  SEM) in the proportion of various n-5 fatty acids in tissues after 12 months 
of supplementation, per gram supplemented with diet 
Increase per g supplemented per day 
EPA ( 2 2 :  5n-3 DHA 
g/100 g fatty ar ih  
Cholesteryl esters 3.94 ? 0.27 ND 1.12 -i- 0.13 
Erythrocytes 2.07 ? 0.11 9.99 t 1.93 1.09 ? 0.21 
Gluteal fat tissue 0.11 ? 0.01 0.55 ? 0.07 0.14 I 0.05 
Abdominal fat tissue 0.12 ? 0.00 0.83 ? 0.07 0.24 ? 0.03 
The highest dose group received 2.4 g / d q  EPA, 0.3 g C22:5n-3, and 0.5 g DHA. ND, not detected. 
the 3 g/d group, +600% in the 6 g/d group and 
+1426% in the 9 g/d group relative to baseline. The 
change was linear with dosage. 
The concentration of DHA increased also (Fig. 1,  bot- 
tom), but changes were much smaller and more erratic 
than for EPA. The calculated half-life for reaching a 
steady state level was 10.3 days, significantly longer than 
the 4.8 days for EPA. The change in DHA was again 
roughly linear with dosage (cf. Fig. 1,  bottom), but each 
g of DHA supplemented per day produced an increase 
of DHA in cholesteryl esters of only 1.1 g/lOO g fatty 
acids, as opposed to 3.9 g/ 1 0 0  g for EPA (Table 5). 
Levels of C22:5n-3 in cholesteryl esters were too low 
for reliable quantitation. 
Red blood cell membranes 
The proportion of EPA in erythrocytes was already 
increased after 3 days of supplementation (Fig. 2, top). 
Crude values were again elevated in all groups at 6 mo; 
thus EPA levels in the placebo control group were 0.8 
throughout the trial but 1.1 at 6 mo. Again, correction 
of all changes for changes in the control group removed 
this effect. The mathematical analysis showed that half- 
maximal concentrations were reached in 28 days (Table 
4). The plateau values (Fig. 2, top) represented changes 
over baseline of +5%, +261%, +482% and +737%, for 
the placebo group, and the 3 g/d,  6 g/d, and 9 g/d 
groups, respectively. The change was linear with dosage, 
with one g of EPA/d, corresponding with about 4 g of 
fish oil, producing an increase in red blood cell mem- 
brane concentrations of 2 g/ 1 0 0  g fatty acids (Table 5). 
Levels of C22 : 5n-3 were somewhat slower to rise than 
those of EPA, the half-life being 39 instead of 28 days 
Table 4 and Fig. 2, middle). The rise in C22:5n-3 in 
erythrocytes was much higher than would be expected 
based on the amount of C22 : 5n-3 supplied; the mean 
increase was 10 g/ 1 0 0  g fatty acids for each gram sup- 
plied per day (Table 5) .  In contrast, DHA in erythro- 
cytes rose by only 1 g fatty acid per gram ingested from 
fish oil (Table 5 ) .  
While EPA and C22 : 5n-3 rose, levels of linoleic and 
-1 C20:5 n-31 
0.8 1 
0 60 120 180 240 300 360 420 480 540 
Time (days) 
Fig. 2. Red blood cells: changes in the levels of EPA (C20:5n-3), 
DPA (C22:5n-5), and DHA (C22:6n-3) as a function of intake at 
various times after the start of supplementation with fish o i l  in 
amoiints of 3 g /d  (0, n = 15), 6 g /d  (A, n = 15), or 9 g /d  (0, 
11 = 14). Values were corrected for changes in the concurrent placebo 
control group (v, n = 14). Top: Eicosapentaenoic acid (EI’A), ( 2 0 :  
5n-3; middle: docosapentaenoic acid (DPA), C22: 511-3; bottom, do- 
cosahexaenoic acid (DHA), C22: 6n-3. 















arachidonic acid declined (Table 3).  Reductions in 
oleic acid were less than 1 g/100 g in all groups. 
When supplementation was suspended, levels of EPA 
and C22:5n-3 came down at approximately the 5ame 
rate at which they had risen (Fig. 2).  Elevations of EPA 
fell to 51% of peak values after 1 month, 37% after 2 
months, and 4% after 6 months (means of the three 
fish oil groups, corrected for placebo). C22: 5n-3 fell 
more slowly. 
Adipose tissue 
The proportion of EPA in gluteal fat aspirates rose 
throughout the 12-month supplementation period, 
without a plateau becoming evident (Fig. 3, top). As in 
the erythrocyte membranes, the relative amount of 
C22:5 n-3 
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Fig. 3. Changes in the levels of very-long-chain in n-3 polyimsatu- 
rated fattv acids in gluteal (buttock) fat tissue aspirates in volunteri-s 
supplemented for I ?  months with 0 g/d ( O ) ,  3 g/d (0), 6 g/d (A) .  
01- 9 g/d (0) o f fish oil rich i n  EPA. Values rcprcsenr changes from 
hiseline corrected for changes in the placebo (0 g,/tl) group. Top 
Eicosapentaenoic acid (EPA4), C?0:5n-3; middlc: tlocosapentaenoic. 
acid (DPA), (:2? :5n-3: bottom, docosahesaenoic arid ([)HA), ( 2 2 :  
611-3. 
C22 : 511-3 incorporated was again much higher than 
that of EPA or DHA (Table 5). Six months after cessa- 
tion of fish oil intake, the elevation of EPA in gluteal 
fat had fallen to 50% and that of DHA to 4.5% of peak 
levels (Fig. 3).  The number of data point? was insuffi- 
cient for calculation of half-lives. 
There was no clear-cut compensatory decline i n  
other fatty acids, possibly because the absolute amounts 
of n-3 fatty acids entering the fat tissue pool were so 
small. 
After 12 months of supplementation, the incr-ease i n  
EPA in abdominal subcutaneous fat tissue was similar 
to that in gluteal fat tissue, but C22:511-.7 and DHA 
were both incorporated more extensively into abdomi- 
nal than into gluteal fat tissue (Table 5). 
DISCUSSION 
We have found that the incorporation half lives of 
EPA into the human body are about 5 days for serum 
cholesteryl esters, almost a month for erythrocytes, and 
longer than a year for subcutaneous fat tissue. The ex- 
tent of incorporation was in general linear with thc 
amount consumed up to 9 grams of fish oil per day. 
These data should provide a firm footing for the use of 
these fatty acids as markers for dietary intake. 
Cholesteryl esters 
The spectrum of fatty acids found in cholesteryl esters 
is largely determined by the specificity of the enzyme 
lecithin :cholesterol acyl transferase (LCAT). LCAT has 
a preference for linoleic acid (C18:2n-6), which is the 
predominant fatty acid in cholesteryl esters even when 
linoleic acid intakes are low. However, the composition 
of cholesteryl esters is influenced by diet; even saturated 
arid trans-monounsaturated fatty acids are incorporated 
in a diet-dependent fashion (25). After I year ofsupple- 
mentation with 9 g of fish oil per day, the ratio of lin- 
oleic acid over EPA was 4.5 in the diet of our subjects, 
including the capsules, and 4.7 in their cholesteryl es- 
ters. Excess linoleic acid was probably also still being 
supplied from Fat stores, in which the ratio of linoleic 
acid to EPA was 38. This suggests that the enzymatic 
pathway leading to cholesteryl ester formation has as 
high an affinity for EPA as for linoleic acid. This con- 
trasts with in vitro studies where LCAT showed a 
marked preference for linoleic acid over (n-3) polyun- 
saturated fatty acids (26, 27). However, Parks, Bullock, 
and Rude (26) already pointed wi t  ihat many factors 
influence the LCAT reaction including phospholipid 
species, lipid environment, and the size and shape of' 
the macromolecular substrate particles. 















The rate of incorporation of EPA into cholesteryl es- 
ters could depend on the turnover rate of the main car- 
rier of cholesteryl esters in serum, LDL. The half-life of 
LDL in middle-aged men is about 3 days, which is of 
the same order of magnitude as the half-life for the in- 
corporation of EPA into cholesteryl esters of 5 days ob- 
served here. This should make the level of EPA in 
cholesteryl esters a suitable indicator of the intake in 
the preceding 1 to 2 weeks. 
The extent of incorporation of EPA as a function of 
diet found by us was in reasonable agreement with Val- 
ues reported previously. Our data predict an increase 
of 3.9 g/lOO g fatty acids for every extra gram of EPA 
eaten per day (Table 5 ) .  From the data of Bronsgeest- 
Schoute et al. (28) one can calculate a ratio of about 
2.3, but this was after only 1 week of supplementation; 
our data show that steady-state levels are not reached 
within that time. 
The increase of DHA in the cholesteryl esters was 
quite small relative to the amount supplied. This is in 
agreement with the data of Bronsgeest-Schoute et al. 
(28) and Von Lossonczy et al. (29) who found no effect 
on cholesteryl ester DHA concentration after supple- 
mentation with high doses of DHA (4.2 g/d) during 4 
weeks. These observations could point to a retroconver- 
sion of DHA into EPA (30) but may also be due to DHA 
being a poor substrate for LCAT (26, 27, 31) or to its 
being less efficiently incorporated into the sn-2 position 
of phosphatidylcholine, which is the substrate for the 
LCAT reaction. 
Erythrocyte membranes 
Mean initial levels in erythrocyte fatty acids were 0.8% 
for EPA, 2.4% for C22:5n-3, and 4.7% for DHA. These 
data are in agreement with published values. Previous 
studies have shown significant increases of erythrocyte 
EPA and DHA levels during supplementation (32, 33). 
In our subjects the rise in erythrocyte EPA was much 
higher than that in DHA, but on a gram per gram basis 
EPA and DHA were incorporated about equally effec- 
tively. In contrast, levels of C22:5n-3 rose markedly 
even though very little was supplemented. This may 
point to formation of C22:5n-3 from EPA, DHA, or 
from both (34). 
Brown, Pang, and Roberts (33) concluded that each 
extra gram of dietary EPA raised erythrocyte EPA by 1.2 
g/100 g fatty acids. This is less than our figure of 2.2. 
However, the median duration of the studies summa- 
rized by Brown et al. was only 9 weeks; according to our 
data that is insufficient to reach a steady state (Fig. 2). 
Brown et al. (33) also suggested that turnover of DHA 
in erythrocyte membranes is slower than that of EPA, 
possibly because DHA is located in the inner leaflet of 
the phospholipid bilayer and does not exchange with 
plasma phospholipids. In our study the time course 
of incorporation of DHA was more erratic than that 
of EPA, which precludes firm conclusions as to its half- 
life. 
Animal studies (35) have suggested that the incorpo- 
ration of essential (n-3) fatty acids into tissues may level 
off when dietary requirements are exceeded. This was 
evidently not the case in these grown men; levels went 
up with intake and did not plateau even at doses that 
clearly exceeded requirements. Such plateauing is thus 
not a valid way to determine requirements in man. 
The lifetime of a red blood cell is about 120 days, but 
we saw a doubling of EPA concentration in erythrocyte 
membranes already at 3 days after the start of the sup- 
plementation. Evidently the red blood cells exchanged 
phospholipids or fatty acids with their environment 
rather easily; possibly the phospholipid transfer protein 
plays a role here. The decrease in (n-3) fatty acids after 
cessation of fish oil supplementation was equally rapid; 
about half of the EPA gained during supplementation 
was lost in the first 4 weeks of the wash-out period. Our 
data on this do not agree with those of Sanders, Vickers, 
and Haines (36) who reported that n-3 composition 
of erythrocyte membranes was unaltered 5 weeks after 
withdrawal. The reason for this discrepancy is unclear. 
Fat tissue 
Levels of linoleic acid in human or animal fat tissue 
closely resemble those in the fat eaten when both are 
expressed as gram per 100 gram of fatty acids. One 
might expect the same relation for the very-long-chain 
n-3 fatty acids. Indeed, basal values for EPA in fat tissue 
in our subjects were similar to those in the diet, at 0.07 
and 0.04 gram per 100 g fatty acids, respectively. Com- 
parable levels have been published by others (10, 18). 
However, after 1 year of fish oil consumption, the pro- 
portion of EPA in abdominal or gluteal fat was only 
about one-sixth and that of DHA about one-third of 
that in the dietary fat. The values for DHA could be 
accounted for if the half-life for incorporation of DHA 
into gluteal fat tissue were assumed to be 2 years; the 
model described in Methods would then yield values in 
fat tissue at 363 days close to those observed, and at t 
= m values identical to those in the diet. The half-life 
for the incorporation of linoleic acid into fat tissue is 
680 days (24); 2 years for DHA is thus a plausible value. 
On the other hand, the values observed for EPA 
could be explained only if the half-life for incorpora- 
tion of EPA were assumed to be 6 years. Such a long 
half-life is implausible in view of the linoleic acid data, 
and it is also incompatible with the fairly rapid rise in 
EPA content of gluteal fat over the first 180 days and 
the equally rapid fall during the wash-out period, be- 
tween days 363 and 540 (Fig. 3, top). One explanation 















could be preferential mobilization of EPA from fat tis- 
sue, as observed by Connor et al. in rabbits ( 3 7 ) .  An- 
other possibility is that part of the dietary EPA is not 
available for incorporation into fat tissue, and that the 
stationary-state levels in body fat will be lower than 
those in the dietary fat. This agrees with some prelimi- 
nary results of Popp-Snijders (38) who suggested that 
adipose tissue triglycerides have a poor affinity for 
omega-3 polyunsaturated fatty acids. 
The opposite phenomenon was seen with C 2 2 :  511-3, 
where the rise in gluteal fat tissue was 4- to 5-fold higher 
than that of' the other two very-long-chain n-3 fatty 
acids relative to the amounts fed (Table 5) .  A possible 
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Fig. 4. Changes in the levels o f  \rei?-long-chaiii 11-3 Ijolyiinsatiii-atctl 
f i t ty  acids in abdoniinal f i t  tissur ,ispirates i i i  volunteers srlpple 
meritetlfor 12moiithswithOg/d (V). Xg/d (O),( ig/d (A).or9gi 
d (0) offish o i l  rich in EPA. \'slues rcprcarnt changrs from hasclinc 
corr-rcted for  changes i n  the placebo (0 g/d)  gIoiip. No ;ihdornin;il 
SAIIlpks were raken at thc end o f  thr  washout pcriod. Top: Eicosn- 
pcntacrroic x i t l  (LI'A), ( 2 0 :  51)-3; midtllc: t1ocosapciitacii~)ic 
acid ( D P A ) ,  (;22:5ii-3; bottom, d~~coa;tlicsacnoic a id (I)€l.A),  ( 2 2 :  
(ii 1-3. 
explanation is again production of C22:  511-3 from EPA 
or DHA in tissues. 
Data from other studies on the level ofn-3 fatty acids 
in body fat as a function of long-term intake are scaIce. 
Leaf and coworkers (39) studied seven patients who had 
received 10-15 g of fish oil per day for periods of 12- 
27 months for the treatment of dyslipidemic disorders; 
five patients not on fish oil treatment plus three voluii- 
teers with a low fish intake served as controls. Levels of 
n-3 fatty acids were markedly elevated in adipose tissue 
as well as in all plasma lipid classes studied, but quantita- 
tive data on incorporation half-life and steady-skte lev- 
els as a function of intake were not available. 
There are a number of indications that fatty acids in  
abdominal fat tissue turn over more rapidly than those 
in gluteal fat tissue. Kather et al. (40) showed that the 
maximal effect of adrenaline o n  adenylate cyclase activ- 
ity was larger in abdorninal than in  gluteal subcutanr- 
o i l s  fat tissue. Field and Clandinin (4 1 )  studied the turn- 
over of labeled fatty acids in human adipose tissue aiicl 
found a half-life of 363 days for gluteal and o P  134 days 
for abdominal fat. In  our subjects levels of DNA arid 
( 2 2 :  5n-3 indeed rose more rapidly in abdominal than 
in glutcal fat (Figs. 3 and 4) ,  but at day 363 they were 
still Par below dietary levels. Either turnovci- times i n  adi- 
pose tissue were longer under our conditions, or t h c :  
levels in abdominal adipose tissue never reach those i l l  
the diet. 
Thus our fat tissue data do n o t  allow estimation o l '  
absolute long-term intakes of' ( 1 1 - 3 )  fatty acids, hut they 
do show that subjects can be ranked hp intake, which is 
all that is required in most epidemiological studies. Our 
data on cholesteql esters and erythrocytes suggest that 
such measurements provide valid estimates of differ- 
ences in intakes over the past weeks and rnontlis, respec- 
tively, and should thus be helpful in ranking subjects 
by intake of 11-3 fdtty acids in free-living popid&- 
tio1is.a 
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